No Data
No Data
No Data
No Data
No Data
T&S CommunicationsLtd (SZSE:300570) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance the T&S
Simply Wall StApr 23 21:37 ET
T&S---Nagoya Office opened
T&S <4055> announced on the 15th that it will open a new office in Nagoya City, Aichi Prefecture. The company provides system development and IT services related to areas such as semiconductors, heavy electronics, and social infrastructure, etc., and in addition to its headquarters in Yokohama City, Kanagawa Prefecture, it is developing operations based on customer bases in Mie Prefecture, Iwate Prefecture, and the Kyushu area. In addition to this, business provision of AI solutions to major automobile manufacturers etc. has also been expanding in recent years, and it has become closer to customers
Fisco JapanApr 17 20:41 ET
T&S--1Q sales increase, sales in the DX Solution category increased by 2 digits
T&S <4055> announced financial results for the 1st quarter (23/12/24 to 2/24) of the fiscal year ending 2024/9 on the 12th. Net sales increased 4.0% from the same period last year to 837 million yen, operating profit decreased 3.7% to 138 million yen, ordinary profit decreased 3.5% to 138 million yen, and quarterly net profit decreased 0.2% to 100 million yen. Sales in the DX Solution category increased 13.0% from the same period last year to 512 million yen. In addition to our main clients, we also include major clients, including new ones
Fisco JapanApr 17 20:36 ET
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
Fisco JapanApr 14 17:23 ET
T&S Sees Parent FY Net Y401.00M
T&S Inc. also released the following forecasts: PARENT Year Ending Sep 2024 Revenue Y3.14 bln Operating Profit Y588.00 mln Pretax Profit Y589.
Dow JonesApr 12 02:01 ET
Bic Camera, Money Forward, Ryohin Keikaku, Takashimaya (12 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/12 (Fri) <1401>mbs <1407>West HD<1418>Interlife <1434>JESCOHD<2153>Ejay HD <2168>Pasona G<2305>Studio Alice <2379>dip
Fisco JapanApr 11 17:30 ET
No Data
No Data